Skip to content
TrialScanner

NCT02107235

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Phase 1CompletedTRAWLead

Registry record

Lead sponsor
Traws Pharma, Inc.
Conditions
Head and Neck Neoplasms; Carcinoma, Squamous Cell
Primary completion
Oct 2014Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02107235 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02107235: Platinum-based Chemoradiother... | TrialScanner